CDKN1A and cancer: POH has been shown to increase p21 expression across several cancer models, including human colon cancer [15,34], murine-transformed mammary epithelial cells [46], human pancreatic adenocarcinoma [49], human breast cancer [52], and human lung adenocarcinoma and squamous cell carcinoma [51].